Innate Pharma Adr (IPHA)

Apr 30, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 By Investing.com - Investing.com India

Apr 30, 2025

Apr 29, 2025

Innate Pharma stock surges on promising preclinical data By Investing.com - Investing.com South Africa

Apr 29, 2025

Apr 29, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 - Investing.com

Apr 29, 2025

Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock By Investing.com - Investing.com South Africa

Apr 24, 2025

Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock - Investing.com

Apr 24, 2025

Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock - Investing.com India

Mar 28, 2025

Mar 28, 2025

Innate Pharma Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 28, 2025

Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances - Investing.com

Mar 27, 2025

Jan 17, 2025

Innate Pharma shares retain Buy rating on long-term strategy - Investing.com

Jan 17, 2025

Dec 23, 2024

AZN Stock Price and Chart — LSE:AZN - TradingView

Dec 23, 2024

Dec 09, 2024

Nebius Group N.V (NASDAQ: NBIS)’s Upward Trend Continues - Stocks Register

Dec 09, 2024

Nov 14, 2024

Earnings call: Innate Pharma Q3 2024 results highlight oncology pipeline - Investing.com

Nov 14, 2024

Nov 14, 2024

Earnings call: Innate Pharma focuses on advancing cancer therapies - Investing.com

Nov 14, 2024

Nov 14, 2024

Earnings call: Innate Pharma focuses on advancing cancer therapies By Investing.com - Investing.com UK

Nov 14, 2024

Aug 06, 2024

Contrast Security Introduces Application Detection and Response (ADR) to Identify and Block Attacks and Zero Days on Applications in Production - Business Wire

Aug 06, 2024

Jun 10, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

Jun 10, 2024

Dec 12, 2022

Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286 - Business Wire

Dec 12, 2022

Apr 29, 2022

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins - Equities.com

Apr 29, 2022

Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021

Sep 02, 2021

IPHA stock surges on upcoming presentation for AstraZeneca-partnered asset - Seeking Alpha

Sep 02, 2021